NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 908 filers reported holding NOVARTIS A G in Q1 2017. The put-call ratio across all filers is 2.34 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,000 | -81.4% | 96 | -82.1% | 0.00% | -100.0% |
| Q1 2018 | $43,000 | -64.5% | 535 | -44.9% | 0.00% | -66.7% |
| Q4 2017 | $121,000 | +45.8% | 971 | 0.0% | 0.01% | +50.0% |
| Q3 2017 | $83,000 | -1.2% | 971 | -4.3% | 0.00% | 0.0% |
| Q2 2017 | $84,000 | +10.5% | 1,015 | -1.7% | 0.00% | 0.0% |
| Q1 2017 | $76,000 | +1.3% | 1,033 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $75,000 | -7.4% | 1,033 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $81,000 | -92.5% | 1,033 | -92.1% | 0.00% | -94.3% |
| Q2 2016 | $1,083,000 | +14.4% | 13,133 | +0.3% | 0.07% | +11.1% |
| Q1 2016 | $947,000 | -15.9% | 13,089 | 0.0% | 0.06% | -17.1% |
| Q4 2015 | $1,126,000 | +2065.4% | 13,089 | +2200.4% | 0.08% | +1800.0% |
| Q3 2015 | $52,000 | -5.5% | 569 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $55,000 | -1.8% | 569 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $56,000 | +7.7% | 569 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $52,000 | – | 569 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |